Colombia is making significant advancements in genetic medicine, particularly in early disease detection. The Centro de Ciencias Omicas, a part of Sura Colombia, is at the forefront of this progress, focusing on identifying potential health issues through in-depth genetic research. This proactive approach involves analyzing human genes to predict and manage health risks before diseases manifest.
A key area of focus is neonatal screening, with the center offering 540 tests designed to detect diseases within the first year of life. This early detection enables timely intervention and management of potential health problems. The center also provides diagnostic services for both hereditary and sporadic cancers, utilizing advanced genomic research to investigate rare diseases. This comprehensive approach allows for personalized risk management and aims to reduce delays in diagnosis, ultimately improving patient outcomes.
Sura’s Centro de Ciencias Omicas is using advanced technologies to transform genetic data into tools for personalized and predictive health services. By integrating clinical knowledge with genomic and computational sciences, the center is contributing to the future of medicine in Colombia, offering services that are both predictive and tailored to the individual needs of patients.